Navigation Links
Telik Announces Third Quarter 2009 Financial Results


Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer and inflammatory diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA®, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA®, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

                                    Telik, Inc.
                             Statements of Operations
                     (In thousands, except per share amounts)

                                        Three Months Ended  Nine Months Ended
                                           September 30,      September 30,
                                           -------------      -------------
                                           2009     2008      2009      2008
                                           ----     ----      ----      ----
    Operating costs and expenses:
      Research and development            $3,416   $4,820   $10,428   $21,251
      General and administrative           2,759    2,822     8,845     8,008
      Restructuring costs                      -      199       951       199
                                             ---      ---       ---       ---
        Total operating costs and
         expenses                          6,175    7,841    2
SOURCE Telik, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
2. Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2
3. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
4. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
5. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
6. Telik Announces Presentation at ASCO Annual Meeting
7. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
8. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
(Date:10/9/2015)... 9, 2015 ® ... einer Kolonoskopie im Rahmen eines Screenings, einer ... NOCT-Studie bewertete auch die Compliance, Sicherheit, Patientenakzeptanz ... ® ) an erwachsenen Patienten vergleicht, die ... einer beobachtenden oder einer diagnostischen Kolonoskopie unterziehen. ...
(Date:10/9/2015)... Maryland , October 9, 2015 ... Inc. (OTCQB: CNBX) has announced its execution of an Intellectual ... & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, related ... company. --> --> ... restructuring of the Company, whereby the Research and Development ...
(Date:10/9/2015)... October 9, 2015 ... The report summarizes key statistics ... status of the manufacturers making it ... direction for companies and individuals interested ... . --> ...
Breaking Medicine Technology:
... Sept. 6, 2011 ContinuumRx and Mississippi Baptist Health ... a new home infusion pharmacy that will ... collaborative model designed to improve patient outcomes with a ... "This partnership will not only improve our core operations ...
... DALLAS and NEW YORK, Sept. 6, 2011 ... ACCP) , a biopharmaceutical company leveraging its proprietary ... cancer supportive care and diabetes, announced that the Company,s ... Annual Healthcare Conference on Monday, September 12th at 2:25p.m., ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... On Saturday, September 26, 2015, 48-year-old ... Championship in Madrid, Spain. Representing both the USA and Sweden in the Speed and ... One-Minute Am Front Crosses, she was awarded 1 Silver and 4 Gold Medals. , ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... serving New Orleans and the surrounding communities, is initiating a combined charity effort ... care for unwanted animals in southern Louisiana. , Animal Rescue New Orleans ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... an upcoming episode of Innovations with Ed Begley Jr., airing 1st QT 2016 ... Innovations will educate audiences on MMJ Phytotech Limited (MMJ) – a global leader ...
(Date:10/9/2015)... ... 09, 2015 , ... Ryan Fox, the founder and CEO ... Colorado, says the latest figures on the state’s sales of legalized marijuana acknowledge ... industry. , Last month, according to the website , Colorado's ...
(Date:10/9/2015)... OR (PRWEB) , ... October 09, 2015 , ... Most ... less processed with more vegetables and less meat. While noted T’ai Chi Master and ... a “Yin and Yang” relationship between the two cuisines and that they potentially complement ...
Breaking Medicine News(10 mins):
... HealthDay Reporter , MONDAY, July 18 (HealthDay News) ... treatment of HIV in an infected heterosexual can protect his ... among 1,763 couples in Africa, Asia, South America and the ... cut their odds of transmitting the virus to their partner ...
... , FRIDAY, July 15 (HealthDay News) -- Although ... relax, the relationship between stress and alcohol is a two-way ... body manages stress, the authors of a new study pointed ... alcohol, causing individuals to drink more to produce the same ...
... July 18 (HealthDay News) --, Women fear Alzheimer,s disease more ... often on the front lines of providing care for loved ... consistently pointing to the fact that more women are living ... clear women are disproportionately affected by this disease," said Angela ...
... and NYU Langone Medical Center have developed a compound ... types of cancer. The compound is described in the ... The researchers examined signaling by receptor ... underlying cause of various developmental disorders and diseases, including ...
... , SATURDAY, July 16 (HealthDay News) -- You ... picnic and just laze around outside, but don,t overdo it: Overexposure ... Protection Agency warns. On average, heat waves kill more people ... And one American dies every hour from skin cancer, the most ...
... home residents taking certain antidepressant medications are at an increased ... a new prescription or a dose increase of their current ... Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical ... Sciences, the study found that nursing home residents have ...
Cached Medicine News:
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: